Industrial Farmacéutica Cantabria, S.A.

Industrial Farmacéutica Cantabria, S.A.

Abrir el Menú Móvil

NEWS

IFC, leader* in oral photoprotection against sun damage

A new study outlining the efficacy of oral Fernblock® against sun damage

 

IFC . 28/06/2017

ifc-group-noticias-2016-ifc-heliocare-en-china

Industrial Farmacéutica Cantabria, leader in oral photoprotection, highlights the importance of oral photoprotection to supplement topical photoprotection for the comprehensive prevention of sun damage, further to the publication of a new study on the efficacy of the IFC ingredient, Fernblock®.

This study led by Dr. Henry Lim, president of the American Academy of Dermatology, and carried out together with experts in photoprotection and photomedicine at the Henry Ford Hospital of Detroit, was recently published in the prestigious scientific “Journal of the American Academy of Dermatology” (JAAD).

In the study, the investigators conclude that Fernblock® prevents the negative photobiological effects of UV radiation, reducing erythema, inflammation and DNA cell damage. This helps to improve the resistance of skin to sun exposure thus demonstrating the efficacy of oral Fernblock® in the prevention of sun damage.

22 healthy subjects took part in the study with phototypes I to III according to the Fitzpatrick scale. These subjects were irradiated with UVB light and 24 hours later they underwent clinical and instrumental examinations. On the following day, irradiation was repeated after the ingestion of 480 mg of Fernblock® and 24 hours later they were assessed again using the same methods.

The clinical and colorimetric assessment showed that the ingestion of 480 mg of Fernblock® reduced erythema caused by UV radiation thus increasing resistance to sunburn. Furthermore, a histological examination of skin biopsies was carried out on patients before and after the ingestion of Fernblock® in which biomarkers were assessed related to DNA damage, inflammation and cell death due to sun exposure. The investigators demonstrated that Fernblock® significantly reduces this damage.

Dr. H. Lim and his team concluded that oral administration of Fernblock® is the ideal supplement to traditional photoprotection (topical, clothing, shade …).

Industrial Farmacéutica Cantabria patented its Fernblock® technology based on the standardised extract of Polypodium Leucotomos (EPL) over 20 years ago.

Fernblock® is the basis of the Heliocare®, range of topical and oral photoprotectors. Thanks to its trusted expertise in this area and extensive scientific endorsement, Heliocare oral photoprotection range has become a leader in sales *.

Oral Heliocare, effective from the first dose and in single doses has 4 products in Spain adapted to the different needs of each individual: Heliocare 360 capsules, Heliocare Ultra D, Heliocare capsules and Heliocare Bronze.

* Leaders in sales of units and in value. Source IMS Sales Units MAT/12/2016. Sales EUROS PUB MAT/12/2016 in category 83F1.

Study reference: Kohli L, et als. “The impact of oral Polypodium leucotomos extract on ultraviolet B response: A human clinical study”. J Am Acad Dermatol. 2017 Jul;77(1):33-41

We use own and third party cookies to improve our services and show you contents related to your browsing habits. If you go on navigating, we will consider you accept its use. Click here to change the settings or get more information.

ACCEPT